For: | Xin SY, Feng XS, Zhou LQ, Sun JJ, Gao XL, Yao GL. Reduced expression of circulating microRNA-218 in gastric cancer and correlation with tumor invasion and prognosis. World J Gastroenterol 2014; 20(22): 6906-6911 [PMID: 24944481 DOI: 10.3748/wjg.v20.i22.6906] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i22/6906.htm |
Number | Citing Articles |
1 |
Qiang Zheng, Changyu Chen, Haiyang Guan, Weibiao Kang, Changjun Yu. Prognostic role of microRNAs in human gastrointestinal cancer: A systematic review and meta-analysis. Oncotarget 2017; 8(28): 46611 doi: 10.18632/oncotarget.16679
|
2 |
Yue Zhang, Dong-Hui Guan, Rong-Xiu Bi, Jin Xie, Chuan-Hua Yang, Yue-Hua Jiang. Prognostic value of microRNAs in gastric cancer: a meta-analysis. Oncotarget 2017; 8(33): 55489 doi: 10.18632/oncotarget.18590
|
3 |
Blanca Ortiz‐Quintero. Cell‐free microRNAs in blood and other body fluids, as cancer biomarkers. Cell Proliferation 2016; 49(3): 281 doi: 10.1111/cpr.12262
|
4 |
Alexander Link, Juozas Kupcinskas. MicroRNAs as non-invasive diagnostic biomarkers for gastric cancer: Current insights and future perspectives. World Journal of Gastroenterology 2018; 24(30): 3313-3329 doi: 10.3748/wjg.v24.i30.3313
|
5 |
Zhandong Zhang, Ye Kong, Wei Yang, Bin Zhang, Fei Ma, Hongxing Liu, Yawei Hua. MicroRNA‑218 enhances gastric cancer cell cisplatin sensitivity by targeting survivin. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6802
|
6 |
Mehrdad Hashemi, Sadaf Gholami, Rasoul Raesi, Sareh Sarhangi, Behnaz Mahmoodieh, Zeinab Khazaei Koohpar, Mohammad Ali Sheikh Beig Goharrizi, Mitra Behroozaghdam, Maliheh Entezari, Shokooh Salimimoghadam, Wenliang Zha, Mohsen Rashidi, Soheila Abdi, Afshin Taheriazam, Noushin Nabavi. Biological and therapeutic viewpoints towards role of miR-218 in human cancers: Revisiting molecular interactions and future clinical translations. Cellular Signalling 2023; 109: 110786 doi: 10.1016/j.cellsig.2023.110786
|
7 |
Le-Le Wang, Lei Wang, Xiao-Ying Wang, Di Shang, Sheng-Jie Yin, Li-Li Sun, Hong-Bo Ji. MicroRNA-218 inhibits the proliferation, migration, and invasion and promotes apoptosis of gastric cancer cells by targeting LASP1. Tumor Biology 2016; 37(11): 15241 doi: 10.1007/s13277-016-5388-0
|
8 |
Leon J Wils, Maarten F Bijlsma. Epigenetic regulation of the Hedgehog and Wnt pathways in cancer. Critical Reviews in Oncology/Hematology 2018; 121: 23 doi: 10.1016/j.critrevonc.2017.11.013
|
9 |
XIANGLIANG ZHANG, HUIJUAN SHI, HONGSHENG TANG, ZHIYUAN FANG, JIPING WANG, SHUZHONG CUI. miR-218 inhibits the invasion and migration of colon cancer cells by targeting the PI3K/Akt/mTOR signaling pathway. International Journal of Molecular Medicine 2015; 35(5): 1301 doi: 10.3892/ijmm.2015.2126
|
10 |
Lei Hu, Huo Wu, Xiao Wan, Liu Liu, Yiren He, Liang Zhu, Shaojun Liu, Hanhui Yao, Zhiqiang Zhu. MicroRNA-585 suppresses tumor proliferation and migration in gastric cancer by directly targeting MAPK1. Biochemical and Biophysical Research Communications 2018; 499(1): 52 doi: 10.1016/j.bbrc.2018.03.116
|
11 |
Wanli Yang, Jiaojiao Ma, Wei Zhou, Xin Zhou, Bo Cao, Hongwei Zhang, Qingchuan Zhao, Daiming Fan, Liu Hong. Molecular mechanisms and clinical implications of miRNAs in drug resistance of esophageal cancer. Expert Review of Gastroenterology & Hepatology 2017; 11(12): 1151 doi: 10.1080/17474124.2017.1372189
|
12 |
Hong-Tai Wang, Ai-Gang Liu, Dao-Shu Luo, Zhang-Nan Zhou, Hong-Guang Lin, Rong-Zi Chen, Jin-Shui He, Kun Chen. miR-218 expression in osteosarcoma tissues and its effect on cell growth in osteosarcoma cells. Asian Pacific Journal of Tropical Medicine 2014; 7(12): 1000 doi: 10.1016/S1995-7645(14)60176-0
|
13 |
Libing Guo, Xiuyu Cai, Weihan Hu, Wenfeng Hua, Wen Yan, Yucheng Lin, Shengsong Yin, Yue Chen. Expression and clinical significance of miRNA-145 and miRNA-218 in laryngeal cancer. Oncology Letters 2019; doi: 10.3892/ol.2019.10353
|
14 |
Chengjun Sui, Feng Xu, Weifeng Shen, Li Geng, Feng Xie, Binghua Dai, Jiongjiong Lu, Minfeng Zhang, Jiamei Yang. Overexpression of miR-218 inhibits hepatocellular carcinoma cell growth through RET. Tumor Biology 2015; 36(3): 1511 doi: 10.1007/s13277-014-2679-1
|
15 |
Ya-Kai Huang, Jian-Chun Yu. Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review. World Journal of Gastroenterology 2015; 21(34): 9863-9886 doi: 10.3748/wjg.v21.i34.9863
|
16 |
Pei-Long Li, Xin Zhang, Li-Li Wang, Lu-Tao Du, Yong-Mei Yang, Juan Li, Chuan-Xin Wang. MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targetingBIRC5. Carcinogenesis 2015; : bgv145 doi: 10.1093/carcin/bgv145
|
17 |
Qiang Ruan, Zhi-yuan Fang, Shu-zhong Cui, Xiang-liang Zhang, Yin-bing Wu, Hong-sheng Tang, Yi-nuo Tu, Yan Ding. Thermo-chemotherapy Induced miR-218 upregulation inhibits the invasion of gastric cancer via targeting Gli2 and E-cadherin. Tumor Biology 2015; 36(8): 5807 doi: 10.1007/s13277-015-3250-4
|
18 |
Fujiao Duan, Kaijuan Wang, Liping Dai, Xia Zhao, Yajing Feng, Chunhua Song, Shuli Cui, Chengzeng Wang. Prognostic significance of low microRNA-218 expression in patients with different types of cancer. Medicine 2016; 95(37): e4773 doi: 10.1097/MD.0000000000004773
|
19 |
Annette A. van Zweeden, Roza C.M. Opperman, Richard J. Honeywell, Godefridus J. Peters, Henk M.W. Verheul, Hans J. van der Vliet, Dennis Poel. The prognostic impact of circulating miRNAs in patients with advanced esophagogastric cancer during palliative chemotherapy. Cancer Treatment and Research Communications 2021; 27: 100371 doi: 10.1016/j.ctarc.2021.100371
|
20 |
Leila Jamali, Roghayeh Tofigh, Sara Tutunchi, Ghodratollah Panahi, Fatemeh Borhani, Saeedeh Akhavan, Parisa Nourmohammadi, Sayyed M.H. Ghaderian, Milad Rasouli, Hamed Mirzaei. Circulating microRNAs as diagnostic and therapeutic biomarkers in gastric and esophageal cancers. Journal of Cellular Physiology 2018; 233(11): 8538 doi: 10.1002/jcp.26850
|
21 |
Jing Zhang, Shengze Li, Yanhua Li, Hongli Liu, Yuan Zhang, Qingsong Zhang. miRNA‑218 regulates the proliferation and apoptosis of cervical cancer cells via targeting Gli3. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6491
|
22 |
HANG TIAN, LEI HOU, YU-MEI XIONG, JUN-XIANG HUANG, YING-JUN SHE, XIAO-BAO BI, XING-RONG SONG. miR-218 suppresses tumor growth and enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin. Oncology Reports 2015; 33(2): 981 doi: 10.3892/or.2014.3657
|
23 |
Chiranjib Chakraborty, Srijit Das. Profiling cell-free and circulating miRNA: a clinical diagnostic tool for different cancers. Tumor Biology 2016; 37(5): 5705 doi: 10.1007/s13277-016-4907-3
|
24 |
Afshin Taheriazam, Amir Jouya Talaei, Mohammad Jamshidi, Mohammadreza Shakeri, Samaneh Khoshbakht, Emad Yahaghi, Marjan Shokrani. RETRACTED ARTICLE: Up-regulation of miR-130b expression level and down-regulation of miR-218 serve as potential biomarker in the early detection of human osteosarcoma. Diagnostic Pathology 2015; 10(1) doi: 10.1186/s13000-015-0422-x
|
25 |
Tianxi Wang, Jun Zhang, Jingjing Tian, Shasha Hu, Rongna Wei, Lihong Cui. Low expression levels of plasma miR‑141 are associated with susceptibility to gastric cancer. Oncology Letters 2019; doi: 10.3892/ol.2019.10390
|
26 |
Ming-Ming Tsai, Chia-Siu Wang, Chung-Ying Tsai, Hsiang-Wei Huang, Hsiang-Cheng Chi, Yang-Hsiang Lin, Pei-Hsuan Lu, Kwang-Huei Lin. Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer. International Journal of Molecular Sciences 2016; 17(6): 945 doi: 10.3390/ijms17060945
|
27 |
Md Mahmodul Hasan Sohel. Circulating microRNAs as biomarkers in cancer diagnosis. Life Sciences 2020; 248: 117473 doi: 10.1016/j.lfs.2020.117473
|
28 |
Prakash C. Sharma, Renu Verma. Recent Advancements in Biomarkers and Early Detection of Gastrointestinal Cancers. Diagnostics and Therapeutic Advances in GI Malignancies 2020; : 73 doi: 10.1007/978-981-15-4431-6_6
|
29 |
Li Liu, Ren’an Chen, Yangping Zhang, Wen Fan, Fang Xiao, Xueqian Yan. Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia. Diagnostic Pathology 2015; 10(1) doi: 10.1186/s13000-015-0345-6
|
30 |
Yunhui Hu, Kun Xu, Ernesto Yagüe. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer. Breast Cancer Research and Treatment 2015; 151(2): 269 doi: 10.1007/s10549-015-3372-9
|
31 |
Silin Chen, Jiaming Zhu, Feifei Yu, Yuxi Tian, Shumei Ma, Xiaodong Liu. Combination of miRNA and RNA functions as potential biomarkers for gastric cancer. Tumor Biology 2015; 36(12): 9909 doi: 10.1007/s13277-015-3756-9
|
32 |
Luis Alejandro Arias Sosa, Bibiana Matilde Bernal Gómez, Andrés Felipe Cuspoca Orduz. Supresión tumoral por microARN en el cáncer gástrico. Gaceta Mexicana de Oncología 2016; 15(4): 222 doi: 10.1016/j.gamo.2016.07.003
|
33 |
Peng Peng, Tao Chen, Qing Wang, Yixi Zhang, Fangfang Zheng, Shuai Huang, Yubo Tang, Chunxiao Yang, Wenqing Ding, Dong Ren, Zongwen Huang, Yuanqing Guo. Decreased miR-218–5p Levels as a Serum Biomarker in Bone Metastasis of Prostate Cancer. Oncology Research and Treatment 2019; 42(4): 165 doi: 10.1159/000495473
|
34 |
María Teresa Corcuera, Cruz Rodríguez-Bobada, Jaime Zuloaga, Fernando Gómez-Aguado, Rosa Rodríguez-Perez, Ángel Mendizabal, Pablo González, Javier Arias-Díaz, María Luisa Caballero. Exploring tumourigenic potential of the parasite Anisakis: a pilot study. Parasitology Research 2018; 117(10): 3127 doi: 10.1007/s00436-018-6008-2
|
35 |
Petra Vychytilova-Faltejskova, Ondrej Slaby. Circulating microRNAs in Disease Diagnostics and their Potential Biological Relevance. Experientia Supplementum 2015; 106: 75 doi: 10.1007/978-3-0348-0955-9_4
|